U.S. flag

An official website of the United States government

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Links from GEO Profiles

Items: 1 to 20 of 196

1.
Syndecan-4 promotes cytokinesis in a phosphorylation-dependent manner
Aniko Keller-Pinter, Sandor Bottka, Jozsef Timar, Janina Kulka, Robert Katona, Laszlo Dux, Ferenc Deak, Laszlo Szilak
Cell Mol Life Sci. 2010 Jun; 67(11): 1881–1894. Published online 2010 Mar 14. doi: 10.1007/s00018-010-0298-6
PMCID:
PMC11115501
AbstractArticlePDF–957K
2.
K48- and K63-linked ubiquitin chain interactome reveals branch- and length-specific ubiquitin interactors
Anita Waltho, Oliver Popp, Christopher Lenz, Lukas Pluska, Mahil Lambert, Volker Dötsch, Philipp Mertins, Thomas Sommer
Life Sci Alliance. 2024 Aug; 7(8): e202402740. Published online 2024 May 21. doi: 10.26508/lsa.202402740
PMCID:
PMC11109483
AbstractArticlePDF–2.9M
3.
RB1 loss induces quiescent state through downregulation of RAS signaling in mammary epithelial cells
Linxiang Gong, Dominic Chih‐Cheng Voon, Joji Nakayama, Chiaki Takahashi, Susumu Kohno
Cancer Sci. 2024 May; 115(5): 1576–1586. Published online 2024 Mar 11. doi: 10.1111/cas.16122
PMCID:
PMC11093197
AbstractArticlePDF–3.4M
4.
Association between syndecan-4 and subclinical atherosclerosis in ankylosing spondylitis
Ahmet L. Sertdemir, Ahmet T. Şahin, Mustafa Duran, Mustafa Çelik, Sefa Tatar, İrem Oktay, Yakup Alsancak
Medicine (Baltimore) 2024 Jan 19; 103(3): e37019. Published online 2024 Jan 19. doi: 10.1097/MD.0000000000037019
PMCID:
PMC10798725
AbstractArticlePDF–640K
5.
Discovery of oncogenic ROS1 missense mutations with sensitivity to tyrosine kinase inhibitors
Sudarshan R Iyer, Kevin Nusser, Kristen Jones, Pushkar Shinde, Clare Keddy, Catherine Z Beach, Erin Aguero, Jeremy Force, Ujwal Shinde, Monika A Davare
EMBO Mol Med. 2023 Oct; 15(10): e17367. Published online 2023 Aug 17. doi: 10.15252/emmm.202217367
PMCID:
PMC10565643
AbstractArticlePDF–2.6M
6.
Therapeutical Options in ROS1—Rearranged Advanced Non Small Cell Lung Cancer
Brigida Stanzione, Alessandro Del Conte, Elisa Bertoli, Elisa De Carlo, Alberto Revelant, Michele Spina, Alessandra Bearz
Int J Mol Sci. 2023 Jul; 24(14): 11495. Published online 2023 Jul 15. doi: 10.3390/ijms241411495
PMCID:
PMC10380455
AbstractArticlePDF–533K
7.
“Evaluation of ROS1 expression and rearrangements in a large cohort of early-stage lung cancer”
Anne Pernille Harlem Dyrbekk, Abdirashid Ali Warsame, Pål Suhrke, Marianne Odnakk Ludahl, Joakim Oliu Moe, Inger Johanne Zwicky Eide, Marius Lund-Iversen, Odd Terje Brustugun
Diagn Pathol. 2023; 18: 70. Published online 2023 May 27. doi: 10.1186/s13000-023-01357-1
PMCID:
PMC10224579
AbstractArticlePDF–1.1M
8.
Syndecan-4 is a maestro of gastric cancer cell invasion and communication that underscores poor survival
Juliana Poças, Catarina Marques, Catarina Gomes, Andreia Hanada Otake, Filipe Pinto, Mariana Ferreira, Tiago Silva, Isabel Faria-Ramos, Rita Matos, Ana Raquel Ribeiro, Emanuel Senra, Bruno Cavadas, Sílvia Batista, Joana Maia, Joana A. Macedo, Luís Lima, Luís Pedro Afonso, José Alexandre Ferreira, Lúcio Lara Santos, António Polónia, Hugo Osório, Mattias Belting, Celso A. Reis, Bruno Costa-Silva, Ana Magalhães
Proc Natl Acad Sci U S A. 2023 May 16; 120(20): e2214853120. Published online 2023 May 8. doi: 10.1073/pnas.2214853120
PMCID:
PMC10193992
AbstractArticlePDF–8.0M
9.
Syndecan-4 Mediates the Cellular Entry of Adeno-Associated Virus 9
Anett Hudák, Matthew Roach, Dávid Pusztai, Aladár Pettkó-Szandtner, Annamária Letoha, László Szilák, Mimoun Azzouz, Tamás Letoha
Int J Mol Sci. 2023 Feb; 24(4): 3141. Published online 2023 Feb 5. doi: 10.3390/ijms24043141
PMCID:
PMC9963952
AbstractArticlePDF–5.3M
10.
Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma
Yu-Fei Cao, Lei Xie, Bei-Bei Tong, Man-Yu Chu, Wen-Qi Shi, Xiang Li, Jian-Zhong He, Shao-Hong Wang, Zhi-Yong Wu, Dan-Xia Deng, Ya-Qi Zheng, Zhi-Mao Li, Xiu-E Xu, Lian-Di Liao, Yin-Wei Cheng, Li-Yan Li, Li-Yan Xu, En-Min Li
Cell Death Differ. 2023 Feb; 30(2): 527–543. Published online 2022 Dec 16. doi: 10.1038/s41418-022-01104-x
PMCID:
PMC9950447
AbstractArticlePDF–8.4M
11.
SNP rs9387478 at ROS1-DCBLD1 Locus is Significantly Associated with Lung Cancer Risk and Poor Survival in Indian Population
Jonita Chongtham, Namita Pandey, Lokesh Kumar Sharma, Anant Mohan, Tapasya Srivastava
Asian Pac J Cancer Prev. 2022 Oct; 23(10): 3553–3561. doi: 10.31557/APJCP.2022.23.10.3553
PMCID:
PMC9924343
AbstractArticlePDF–523K
12.
ROS1 genomic rearrangements are rare actionable drivers in microsatellite stable colorectal cancer
Dilara Akhoundova, Saskia Hussung, Smruthy Sivakumar, Antonia Töpfer, Markus Rechsteiner, Abdullah Kahraman, Fabian Arnold, Florian Angst, Christian Britschgi, Martin Zoche, Holger Moch, Achim Weber, Ethan Sokol, Ralph M. Fritsch
Int J Cancer. 2022 Dec 15; 151(12): 2161–2171. Published online 2022 Aug 30. doi: 10.1002/ijc.34257
PMCID:
PMC9804412
AbstractArticlePDF–4.2M
13.
HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation
Jingsheng Yuan, Tao Lv, Jian Yang, Zhenru Wu, Lvnan Yan, Jiayin Yang, Yujun Shi, Li Jiang
Cell Mol Gastroenterol Hepatol. 2023; 15(2): 307–325. Published online 2022 Oct 14. doi: 10.1016/j.jcmgh.2022.10.005
PMCID:
PMC9772558
AbstractArticlePDF–8.2M
14.
High expression of syndecan-4 is related to clinicopathological features and poor prognosis of pancreatic adenocarcinoma
Yufei Zhu, Dijie Zheng, Linhan Lei, Kun Cai, Huahua Xie, Jian Zheng, Chao Yu
BMC Cancer. 2022; 22: 1042. Published online 2022 Oct 5. doi: 10.1186/s12885-022-10128-y
PMCID:
PMC9533499
AbstractArticlePDF–4.7M
15.
HSF1 phosphorylation establishes an active chromatin state via the TRRAP–TIP60 complex and promotes tumorigenesis
Mitsuaki Fujimoto, Ryosuke Takii, Masaki Matsumoto, Mariko Okada, Keiich I. Nakayama, Ryuichiro Nakato, Katsunori Fujiki, Katsuhiko Shirahige, Akira Nakai
Nat Commun. 2022; 13: 4355. Published online 2022 Jul 29. doi: 10.1038/s41467-022-32034-4
PMCID:
PMC9338313
AbstractArticlePDF–2.8M
16.
Mesoglycan connects Syndecan‐4 and VEGFR2 through Annexin A1 and formyl peptide receptors to promote angiogenesis in vitro
Emanuela Pessolano, Raffaella Belvedere, Nunzia Novizio, Amelia Filippelli, Mauro Perretti, James Whiteford, Antonello Petrella
FEBS J. 2021 Nov; 288(22): 6428–6446. Published online 2021 Jun 22. doi: 10.1111/febs.16043
PMCID:
PMC9290969
AbstractArticlePDF–4.9M
17.
Plasma membrane proteoglycans syndecan-2 and syndecan-4 engage with EGFR and RON kinase to sustain carcinoma cell cycle progression
DeannaLee M. Beauvais, Scott E. Nelson, Kristin M. Adams, Noah A. Stueven, Oisun Jung, Alan C. Rapraeger
J Biol Chem. 2022 Jun; 298(6): 102029. Published online 2022 May 13. doi: 10.1016/j.jbc.2022.102029
PMCID:
PMC9190016
AbstractArticlePDF–2.8M
18.
Physical and functional interactome atlas of human receptor tyrosine kinases
Kari Salokas, Xiaonan Liu, Tiina Öhman, Iftekhar Chowdhury, Lisa Gawriyski, Salla Keskitalo, Markku Varjosalo
EMBO Rep. 2022 Jun; 23(6): e54041. Published online 2022 Apr 5. doi: 10.15252/embr.202154041
PMCID:
PMC9171411
AbstractArticlePDF–1.9M
19.
Clinical characteristics of non‐small cell lung cancer patients with EGFR mutations and ALK&ROS1 fusions
Qinghua Liu, Qingyan Huang, Zhikang Yu, Heming Wu
Clin Respir J. 2022 Mar; 16(3): 216–225. Published online 2022 Jan 26. doi: 10.1111/crj.13472
PMCID:
PMC9060101
AbstractArticlePDF–1.0M
20.
Clinical and economic impact of ‘ROS1-testing’ strategy compared to a ‘no-ROS1-testing’ strategy in advanced NSCLC in Spain
Federico Rojo, Esther Conde, Héctor Torres, Luis Cabezón-Gutiérrez, Dolores Bautista, Inmaculada Ramos, David Carcedo, Natalia Arrabal, J. Francisco García, Raquel Galán, Ernest Nadal
BMC Cancer. 2022; 22: 292. Published online 2022 Mar 19. doi: 10.1186/s12885-022-09397-4
PMCID:
PMC8933896
AbstractArticlePDF–1.9M

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Filter your results:

Find related data

Recent activity

You are here: NCBI > Literature > PubMed Central (PMC)
Support Center